新型受体偏向性IL-2组合改善免疫细胞命运及肿瘤免疫治疗效果
北京大学药学院分子与细胞药理学系
Reshape the fates of Treg and CD8+ T cells through IL-2Rα by synergizing divergent receptor-biased IL-2 PEGylates
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2025, (5): 496
-496
.
>
>